Virtual Incision said today it raised $18 million in a Series B funding round to support FDA 510(k) submission for its next-gen minimally-invasive robotically assisted surgical device.
The round was co-led by newly invested Sinopharm Capital and existing investor BlueStem Capital and was joined by PrairieGold Venture Partners and other investors, the company said.
